In a newborn with hemolytic disease of the newborn due to Rh incompatibility who meets criteria for exchange transfusion, what is the recommended management?

Management of Neonatal Rh Incompatibility Requiring Exchange Transfusion

In a newborn with hemolytic disease due to Rh incompatibility who meets criteria for exchange transfusion, immediately initiate intensive phototherapy, administer IVIG 0.5–1 g/kg over 2 hours, prepare blood for exchange transfusion, and perform the exchange if total serum bilirubin (TSB) reaches ≥20–25 mg/dL (depending on age and risk factors) or if any signs of acute bilirubin encephalopathy appear, regardless of bilirubin level. 1, 2

Immediate Actions When Exchange Transfusion Criteria Are Met

Intensive Phototherapy Initiation

• Start intensive phototherapy immediately using blue-green LED light (430–490 nm wavelength) delivering irradiance ≥30 µW/cm²/nm over maximal body surface area. 1, 3, 2
• Remove the infant's diaper, position the light source as close as safely possible, and line the bassinet with reflective material (aluminum foil or white cloth) to maximize light exposure. 3, 2
• Add a fiber-optic pad beneath the infant in addition to overhead phototherapy to increase effective irradiance. 3

IVIG Administration for Isoimmune Hemolytic Disease

• Administer IVIG 0.5–1 g/kg intravenously over 2 hours when TSB is within 2–3 mg/dL of the exchange transfusion threshold or continues to rise despite intensive phototherapy. 1, 2
• IVIG reduces the need for exchange transfusion by 60–75% (relative risk 0.27) in confirmed isoimmune hemolytic disease with evidence of ongoing hemolysis. 1
• A repeat dose may be given after 12 hours if TSB continues to rise or remains critically elevated. 1, 4
• Critical requirement: IVIG must only be used when the direct antiglobulin test (DAT/Coombs) is positive, confirming isoimmune hemolysis. 1

Blood Preparation and Laboratory Monitoring

• Immediately send blood for type and crossmatch to prepare O-negative, CMV-negative, irradiated packed red blood cells for exchange transfusion. 5, 2
• Obtain complete blood count with differential, reticulocyte count, serum albumin, total and direct bilirubin, maternal and infant blood types, and direct Coombs test. 3, 2
• Measure TSB every 2–3 hours when levels are ≥25 mg/dL, every 3–4 hours for TSB 20–25 mg/dL, and every 4–6 hours for TSB <20 mg/dL. 1, 2

Absolute Indications for Exchange Transfusion

Clinical Signs of Acute Bilirubin Encephalopathy

• Perform exchange transfusion immediately if any of the following signs appear, regardless of bilirubin level: 2
  • Lethargy or marked decrease in activity
  • Poor feeding or refusal to feed
  • High-pitched cry
  • Hypotonia (floppiness) or hypertonia (stiffness)
  • Opisthotonus (arching of back) or retrocollis (arching of neck)
  • Seizures or fever

TSB Thresholds for Exchange Transfusion

• For infants ≥38 weeks gestation: Exchange transfusion is indicated when TSB reaches ≥20–25 mg/dL depending on age in hours and presence of neurotoxicity risk factors. 2
• For infants 35–37 6/7 weeks gestation or with isoimmune hemolytic disease: Exchange transfusion threshold is ≥18–20 mg/dL. 2
• TSB ≥25 mg/dL at any age is a medical emergency requiring immediate exchange transfusion preparation. 3, 2

Failure of Intensive Phototherapy

• Exchange transfusion is necessary when TSB continues to rise despite intensive phototherapy and IVIG, or when TSB fails to decline after 6 hours of intensive phototherapy. 2
• Expected response to intensive phototherapy is a decline of ≥0.5–1 mg/dL per hour during the first 4–8 hours, or >2 mg/dL within 4–6 hours. 3

Exchange Transfusion Procedure Requirements

Safety and Personnel

• Exchange transfusion must only be performed by trained personnel in a neonatal intensive care unit with full monitoring and resuscitation capabilities. 2
• Transfer the infant directly to a pediatric service or NICU; do not route through the emergency department to avoid treatment delays. 2

Blood Product Specifications

• Use O-negative, CMV-negative, irradiated packed red blood cells reconstituted with fresh frozen plasma to achieve a hematocrit of approximately 50–60%. 5
• Double-volume exchange transfusion (160–200 mL/kg) is performed to remove maternal antibodies and replace hemolyzed red blood cells. 5, 6

Concurrent Supportive Management

Hydration and Nutrition

• Continue breastfeeding or bottle-feeding every 2–3 hours during phototherapy to promote bilirubin excretion. 1, 3
• Provide IV fluid supplementation if weight loss exceeds 12% of birth weight or if clinical dehydration is evident. 1, 3

Monitoring for Ongoing Hemolysis

• A reticulocyte count ≥6% or a bilirubin rise of ≥0.3 mg/dL per hour in the first 24 hours (or ≥0.2 mg/dL per hour thereafter) indicates active hemolysis requiring urgent escalation. 3
• Serum albumin <3.0 g/dL increases neurotoxicity risk and lowers the threshold for exchange transfusion. 3, 2

Critical Pitfalls to Avoid

• Do not subtract direct (conjugated) bilirubin from total bilirubin when making treatment decisions unless the direct fraction is ≥50% of total (which requires specialist consultation for cholestasis). 3, 2
• Do not delay exchange transfusion while waiting for IVIG to take effect if TSB reaches exchange threshold or if any signs of encephalopathy appear. 1, 2
• Do not use IVIG when the direct Coombs test is negative, even if ABO incompatibility exists, as this indicates non-immune jaundice. 1
• Do not rely on visual assessment alone; always obtain objective TSB measurement. 3, 2

Post-Exchange Transfusion Management

• Monitor TSB every 2–3 hours after exchange transfusion to detect rebound hyperbilirubinemia. 1
• Continue intensive phototherapy until TSB falls below 13–14 mg/dL. 1, 3
• Infants may require top-up transfusions in the weeks following exchange transfusion due to ongoing hemolysis and bone marrow suppression. 5
• Arrange follow-up within 24–48 hours after discharge to monitor for late anemia and rebound jaundice. 3